NASDAQ
Ekso Bionics Holdings, Inc. (EKSO) has a fcf yield of -57.20% as of Friday, May 29, 2026. This represents a 7.29% increase compared to its 12-month average of -61.69%. Free cash flow yield measures free cash flow per share as a percentage of the stock price, indicating cash return potential.
No price data available for this timeframe.